Nonprescription Drugs Advisory Committee

Executive Summary

Eric Brass, MD/PhD, Harbor-UCLA Medical Center, to acting chair and heir apparent upon expiration of four-year term of former chair Ralph D'Agostino, PhD, Boston University on May 31. D'Agostino continues to participate in the committee as consultant who may vote on issues on a meeting-by-meeting basis. If Brass is to become chairman, his nomination will likely be approved in about two months, along with nominations to replace three other committee vacancies left by Cage Johnson, MD, University of Southern California, Beth Slingluff, Carondelet St. Mary's Hospital (Tucson, Ariz.) and Theodore Tong, University of Arizona College of Pharmacy...